Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity

Arthritis Research and Therapy

Volumn 11, Issue 4, 2009, Pages

  Toussirot, Éric ^a,b,c   Saas, Philippe ^b   Deschamps, Marina ^b   Pouthier, Fabienne ^d   Perrot, Lucille ^b,c   Perruche, Sylvain ^b   Chabod, Jacqueline ^d   Tiberghien, Pierre ^b,d   Wendling, Daniel ^a,b  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c HÔPITAL SAINT JACQUES   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; MESSENGER RNA; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; SOLUBLE CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; ISOPROTEIN; LEUKOCYTE ANTIGEN;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; RNA TRANSCRIPTION; SPONDYLOARTHROPATHY; T LYMPHOCYTE SUBPOPULATION; ADOLESCENT; AGED; BIOSYNTHESIS; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANTIGENS, CD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPONDYLARTHROPATHIES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 68949149643     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2747     Document Type: Article

References (35)

1. Calin A Terminology, introduction, diagnostic criteria, and overview The spondylarthritides Oxford: Oxford University Press Calin A, Taurog JD 1998:1-15.
2. Hammer RE Maika SD Richardson JA Tang JP Taurog JD Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2 microglobulin: An animal model of HLA-B27 associated disorder Cell 1990, 63:1099-1112. 10.1016/0092-8674(90)90512-D 2257626
3. Pachebo-Tena C Zhang X Stone M Burgos-Vargas R Inman R Innate immunity in host-microbial interactions: Beyond B27 in the spondylarthropathies Curr Opin Rheumatol 2002, 14:373-382. 10.1097/00002281-200207000-00007 12118170
4. Baeten D Demetter P Cuvelier C Van Den Bosch Kruithof E Van Damme N Verbuggen G Mielants H Veys EM De Keyser F Comparative study of the synovial histology in rheumatoid arthritis, spondylarthropathy, and osteoarthritis: Influence of disease duration and activity Ann Rheum Dis 2000, 59:945-953. 10.1136/ard.59.12.945 1753054 11087697
5. Laloux L Voisin MC Allain J Martin N Kerboull L Chevalier X Claudepierre P Immunohistological study of entheses in spondylarthropathies: comparison in rheumatoid arthritis and osteoarthritis Ann Rheum Dis 2001, 60:316-321. 10.1136/ard.60.4.316 1753596 11247858
6. Toussirot E Wendling D The immunogenetics of ankylosing spondylitis Rev Med Interne 2006, 27:762-771. 10.1016/j.revmed.2006.05.005 16782239
7. Lenschow DJ Walunas TL Bluestone JA CD28/B7 system of T cell costimulation Annu Rev Immunol 1996, 14:233-258. 8717514 10.1146/ annurev.immunol.14.1.233
8. Teft WA Kirchhof MG Madrenas J A molecular perspective of CTLA-4 function Annu Rev Immunol 2006, 24:65-97. 10.1146/ annurev.immunol.24.021605.090535 16551244
9. Carreno BM Bennett F Chau TA Ling V Luxenberg D Jussif J Baroja ML Madrenas J CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression J Immunol 2000, 165:1352-1356. 10903737
10. Wing K Onishi Y Prieto-Martin P Yamaguchi T Miyara M Fehervari Z Nomura T Sakaguchi S CTLA-4 control over Foxp3+ regulatory T cell function Science 2008, 322:271-275. 10.1126/science.1160062 18845758
11. Oaks M Hallett K Penwell RT Stauber EC Warren SJ Tector AJ A native soluble form of CTLA-4 Cell Immunol 2000, 201:144-153. 10.1006/ cimm.2000.1649 10831323
12. Pawlak E Kochanowska IE Frydecka I Kielbinski M Potoczek S Bilinska M The soluble CTLA-4 receptor: A new marker in autoimmunes diseases Arch Immunol Ther Exp (Warsz) 2005, 53:336-341. 16088318
13. Oaks MK Hallett KM Cutting edge: A soluble form of CTLA-4 in patients with autoimmune thyroid disease J Immunol 2000, 164:5015-5018. 10799854
14. Wang XB Kakuolidou M Giscombe R Qiu Q Huang DR Pirskanen R Lefvert AK Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: Effect of an AT-rich sequence J Neuroimmunol 2002, 130:224-232. 10.1016/S0165-5728(02)00228-X 12225905
15. Liu MF Wang CR Chen PC Fung LL Increased expression of soluble cytotoxic T lymphocyte associated antigen-4 molecule in patients with systemic lupus erythematosus Scand J Immunol 2003, 57:568-572. 10.1046/ j.1365-3083.2003.01232.x 12791095
16. Wong CK Lit LCW Tam LS Li EK Lam CWK Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus Rheumatology 2005, 44:989-994. 10.1093/ rheumatology/keh663 15870153
17. Sato S Fujimoto M Hasegawa M Komura K Yanaba K Hayakawa I Matsushita T Takehara K Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis Rheumatology 2004, 43:1261-1266. 10.1093/ rheumatology/keh303 15266059
18. Ueda H Howson JM Esposito L Heward J Snook H Chamberlain G Rainbow DB Hunter KM Smith AN Di Genova G Herr MH Dahlman I Payne F Smyth D Lowe C Twells RC Howlett S Healy B Nutland S Rance HE Everett V Smink LJ Lam AC Cordell HJ Walker NM Bordin C Hulme J Motzo C Cucca F Hess JF et al Association of T cell regulatory gene CTLA-4 with susceptibility to autoimmune disease Nature 2003, 423:506-511. 10.1038/nature01621 12724780
19. Dougados M Linden van der S Juhlin R Huitfeldt B Amor B Calin A Cats A Dijkmans B Olivieri I Pasero G The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy Arthritis Rheum 1991, 34:1218-1227. 10.1002/art.1780341003 1930310
20. Garrett P Jenkinsson T Kennedy LG Whitelock H Gaisford P Calin A A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index J Rheumatol 1994, 21:2286-2291. 7699630
21. Calin A Garrett S Whitelock H Kennedy LG O'Hea J Mallorie P Jenkinson T A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index (BASFI) J Rheumatol 1994, 21:2281-2285. 7699629
22. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302 3358796
23. Tan EM Cohen AS Fries JF Masi AT McShane DJ Rothfield NF Schaller JG Talal N Winchester RJ The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101 7138600
24. Reimann KA O'Gorman MR Spritzler J Wilkening CL Sabath DE Helm K Campbell DE Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: Evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. The NIAID DAIDS New Technologies Evaluation Group Clin Diagn Lab Immunol 2000, 7:344-351. 95877 10799444
25. Tran DQ Ramsey H Shevach EM Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype Blood 2007, 110:2983-2990. 10.1182/blood-2007-06-094656 2018674 17644734
26. Pfaffl MW A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 2001, 29:e45. 10.1093/nar/29.9.e45 55695 11328886
27. Agarwal SK Marshall GD Jr Role of CD28/B7 costimulation in the dexamethasone-induced suppression of IFN-gamma J Interferon Cytokine Res 2000, 20:927-934. 10.1089/10799900050198363 11096449
28. Qin XJ Shi HZ Qin SM Kang LF Huang CP Zhong XN Effects of allergen inhalation and oral glucocorticoid on serum soluble CTLA-4 in allergic asthmatics Allergy 2005, 60:774-779. 10.1111/j.1398-9995.2005.00784.x 15876307
29. Hacquard-Bouder C Flagarone G Bosquet A Smaoui F Monnet D Ittah M Breban M Defective costimulatory function is a striking feature of antigen presenting cells in an HLA-B27 transgenic rat model of spondylarthropathy Arthritis Rheum 2004, 50:1624-1635. 10.1002/art.20211 15146433
30. Cao D Van Vollenhoven R Klareskog L Trollmo C Malmstrom V CD25 bright CD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease Arthritis Res Ther 2004, 6:R335-346. 10.1186/ ar1192 464877 15225369
31. Manzotti CN Tipping H Perry LC Mead KI Blair PJ Zheng Y Sansom DM Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory cells Eur J Immunol 2002, 32:2888-2896. 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F 12355442
32. Liu MF Kohsaka H Sakurai H Azuma M Okumura K Saito I Miyasaka N The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium Arthritis Rheum 1996, 39:110-114. 10.1002/ art.1780390115 8546719
33. Ehrenstein MR Evans JG Singh A Moore S Warnes G Isenberg DA Mauri C Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF alpha therapy J Exp Med 2004, 200:277-285. 10.1084/ jem.20040165 2211983 15280421
34. Flores-Borja F Jury EC Mauri C Ehrenstein MR Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis Proc Natl Acad Sci USA 2008, 105:19396-19401. 10.1073/ pnas.0806855105 2614772 19036923
35. Olivieri I D'Angelo S Mennillo GA Pistone G Scarano E Padula A Abatacept in spondyloarthritis refractory to tumour necrosis factor alpha inhibition Ann Rheum Dis 2009, 68:151-152. 10.1136/ard.2008.097030 19088259